On October 15, CANSINOBIO rose 5.52% in regular trading, trading at HK$31.7, with turnover of HK$94.039 million.

The clearest recent catalyst is the company’s announcement that its board will meet on October 27 to review and approve results for the nine months ended September 30 and the related release arrangements, putting the upcoming October 28 earnings disclosure back in focus.

Supporting context is that the company recently disclosed a government subsidy of RMB2.8663 million, recognized in current income and equivalent to 10.28% of the prior audited net profit. Earlier disclosures also showed first-half revenue of about RMB547 million, up 46.1% year on year, while adjusted net loss narrowed sharply to RMB0.721 million, suggesting investors remain sensitive to both earnings timing and incremental profit support.

The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.